Ruggero Lasala

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Smoking Cessation

Drug Administration

Small Cell Lung Cancer

Top Venues

European journal of clinical pharmacology

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

European journal of hospital pharmacy : science and practice

European journal of clinical nutrition

This page only lists publications with an associated author ORCID identifier.

Publications

Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri, Valentina Isgrò, Corrado Confalonieri, Alberto Costantini, Fiorenza Enrico, Gianluca Russo, Piera Polidori, Alessandra Di Paolo, Francesco Malorgio, Giordano Beretta, Felice Musicco
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer. European journal of clinical pharmacology 80 (4) (2024)
Andrea Zovi, Carlo Cifani, Corrado Confalonieri, Ruggero Lasala, Michela Sabbatucci, Antonio Vitiello, Sauro Vittori
Dietary management and access to treatment for patients with glucose deficiency syndrome type 1: an overview review with focus on the European regulatory framework. European journal of clinical nutrition (2024)
Felice Musicco, Chiara Fulgenzio, Antonia La Malfa, Nicoletta Jannitti, Antonietta Vitiello, Silvia Carpano, Francesca Fusco, Federico Cappuzzo, Irene Terrenato, Isabella Sperduti, Piera Polidori, Domenico Tarantino, Lidia Di Cerbo, Marcello Pani, Valentina Isgrò, Ruggero Lasala
A real-world multicentre evaluation of atezolizumab plus platinum-etoposide chemotherapy as first-line treatment in patients with extensive-stage small cell lung cancer in Italy. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri, Valentina Isgrò, Corrado Confalonieri, Alberto Costantini, Fiorenza Enrico, Gianluca Russo, Piera Polidori, Alessandra Di Paolo, Francesco Malorgio, Giordano Beretta, Felice Musicco
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer. European journal of clinical pharmacology 80 (4) (2024)
Ruggero Lasala, Alessia Romagnoli, Fiorenzo Santoleri, Valentina Isgrò, Corrado Confalonieri, Alberto Costantini, Fiorenza Enrico, Gianluca Russo, Piera Polidori, Alessandra Di Paolo, Francesco Malorgio, Giordano Beretta, Felice Musicco
The lack of head-to-head randomised trials and the consequences for patients and national health service: The case of non-small cell lung cancer. European journal of clinical pharmacology (2024)
Andrea Zovi, Carlo Cifani, Corrado Confalonieri, Ruggero Lasala, Michela Sabbatucci, Antonio Vitiello, Sauro Vittori
Dietary management and access to treatment for patients with glucose deficiency syndrome type 1: an overview review with focus on the European regulatory framework. European journal of clinical nutrition (2024)
Ruggero Lasala, Paolo Abrate, Andrea Zovi, Fiorenzo Santoleri
Safety and Effectiveness of Multiple Switching Between Originators and Biosimilars: Literature Review and Status Report on Interchangeability. Therapeutic innovation & regulatory science (2022)
Andrea Zovi, Fiorenzo Santoleri, Ruggero Lasala
Conflict of interest declarations in published healthcare reports and the need for supportive legislative frameworks: focus on hospital pharmacists' research activity worldwide. European journal of hospital pharmacy : science and practice (2022)
Ruggero Lasala, Fiorenzo Santoleri, Alessia Romagnoli, Paolo Abrate, Felice Musicco, Alberto Costantini
Medication adherence reporting in pivotal clinical trials: overview of oral oncological drugs. European journal of hospital pharmacy : science and practice (2022)
Felice Musicco, Ruggero Lasala, Fiorenzo Santoleri, Alberto Costantini, Paolo Abrate, Maria Teresa Carretta, Enrica Maria Proli, Alessia Romagnoli, Nicola Petragnani, Francesco De Vita, Massimo Zeuli, Patrizia Vici, Massimo Sansone, Matilde Pasquantonio, Antonia La Malfa, Chiara Fulgenzio
A multicentre study with real-world data of the use of palbociclib in the treatment of breast cancer: Treatment duration correlates with dose reductions. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)
Ruggero Lasala, Fiorenzo Santoleri, Alessia Romagnoli, Felice Musicco, Paolo Abrate, Alberto Costantini
Randomized clinical trials and real life studies: Comparison of baseline characteristics of patients in oral target therapies for renal cell carcinoma. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Ruggero Lasala, Fiorenzo Santoleri
Association between adherence to oral therapies in cancer patients and clinical outcome: a systematic review of the literature. British journal of clinical pharmacology (2021)
Ruggero Lasala, Fiorenzo Santoleri, Davide Zanon, Alessia Romagnoli, Paolo Abrate, Alberto Costantini, Felice Musicco
Available information about paediatric use of onco-haematological drugs authorized by EMA since 2016. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2021)
Ruggero Lasala, Andrea Logreco, Alessia Romagnoli, Fiorenzo Santoleri, Felice Musicco, Alberto Costantini
Cancer drugs for solid tumors approved by the EMA since 2014: an overview of pivotal clinical trials. European journal of clinical pharmacology 76 (6) (2020)